Digest Network Come funziona
Network
/
Società
bi
Non verificato

bioAffinity Technologies, Inc.

Di cosa scriviamo

BiotecnologiaMedicina - VarieOncologiaSaluteScienza

87 comunicati stampa

Guarda tutti i comunicati
27/07/2026
Industria
Biotecnologia
Salute
Oncologia
bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
22/07/2026
Mercato del lavoro
Scienza
Medicina nucleare
Farmaceutica
Oncologia
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Igiene alimentare
Salute
bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
07/07/2026
Scienza
Biotecnologia
Oncologia
Salute
Sanità
Pubblico Esercizio/Vendita al dettaglio
Industria
bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
22/06/2026
Eventi
Fiere
Industria
Software
Scienza
Sanità
Farmaceutica
Oncologia
Tecnica
Biotecnologia
Medicina - Varie
Salute
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
18/06/2026
Mercato azionario
Medicina nucleare
Farmaceutica
Oncologia
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Igiene alimentare
Salute
bioAffinity Technologies Announces Closing of $3.2 Million Offering
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
17/06/2026
Titoli e azioni
Biotecnologia
Attrezzature medico-sanitarie
Salute
Oncologia
bioAffinity Technologies Announces Pricing of $3.2 Million Offering
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
16/06/2026
Web e Social Network
Mercato del lavoro
Eventi
Biotecnologia
Salute
Medicina nucleare
Farmaceutica
Medicina - Varie
Difesa / Forze Armate
Oncologia
Scienza
Attrezzature medico-sanitarie
bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
02/06/2026
Scienza
Biotecnologia
Medicina - Varie
Oncologia
Salute
Tecnica
Web e Social Network
Industria
Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
27/05/2026
Scienza
Medicina nucleare
Farmaceutica
Oncologia
Attrezzature medico-sanitarie
Biotecnologia
Medicina - Varie
Igiene alimentare
Salute
bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0
12/05/2026
Industria
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Sanità
Salute
Oncologia
bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026
Fonte
bioAffinity Technologies, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0